2023 Q3 Form 10-Q Financial Statement

#000149315223027845 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $2.409M $2.900M
YoY Change -42.49% -45.32%
Cost Of Revenue $669.8K $845.8K
YoY Change -61.94% -48.96%
Gross Profit $1.739M $2.032M
YoY Change -28.39% -44.27%
Gross Profit Margin 72.19% 70.08%
Selling, General & Admin $2.859M $3.709M
YoY Change -56.65% -49.26%
% of Gross Profit 164.43% 182.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $129.3K $178.2K
YoY Change -21.43% 4.2%
% of Gross Profit 7.43% 8.77%
Operating Expenses $2.859M $3.709M
YoY Change -56.65% -49.26%
Operating Profit -$1.120M -$1.676M
YoY Change -73.11% -54.23%
Interest Expense $1.963M $905.8K
YoY Change -40.89% -70.97%
% of Operating Profit
Other Income/Expense, Net -$346.5K -$736.0K
YoY Change -97.65% -137.37%
Pretax Income -$1.467M -$2.412M
YoY Change -92.26% 42.5%
Income Tax -$12.10K $12.10K
% Of Pretax Income
Net Earnings -$1.455M -$2.424M
YoY Change -92.09% 79.18%
Net Earnings / Revenue -60.4% -83.6%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 376.3M shares 376.3M shares
Diluted Shares Outstanding 376.3M shares 370.9M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.385M $1.370M
YoY Change -78.55% -90.52%
Cash & Equivalents $1.385M $1.370M
Short-Term Investments
Other Short-Term Assets $222.4K $1.063M
YoY Change -85.37% -56.22%
Inventory $2.201M $1.478M
Prepaid Expenses
Receivables $434.2K $532.4K
Other Receivables $1.800M $0.00
Total Short-Term Assets $6.043M $4.443M
YoY Change -55.24% -80.6%
LONG-TERM ASSETS
Property, Plant & Equipment $377.7K $466.5K
YoY Change -96.05% -95.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $1.184M $1.184M
YoY Change 1.08% 594.04%
Total Long-Term Assets $2.462M $2.597M
YoY Change -87.55% -87.6%
TOTAL ASSETS
Total Short-Term Assets $6.043M $4.443M
Total Long-Term Assets $2.462M $2.597M
Total Assets $8.505M $7.041M
YoY Change -74.44% -83.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.060M $1.001M
YoY Change 12.69% 74.07%
Accrued Expenses $947.7K $5.282M
YoY Change 4.97% 1291.69%
Deferred Revenue
YoY Change
Short-Term Debt $1.200M $0.00
YoY Change -89.04% -100.0%
Long-Term Debt Due $0.00 $24.66M
YoY Change -100.0% 251.43%
Total Short-Term Liabilities $8.009M $31.23M
YoY Change -72.97% 49.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $416.3K $427.2K
YoY Change 0.65% -7.44%
Total Long-Term Liabilities $416.3K $427.2K
YoY Change 0.65% -7.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.009M $31.23M
Total Long-Term Liabilities $416.3K $427.2K
Total Liabilities $8.426M $31.65M
YoY Change -71.96% 44.31%
SHAREHOLDERS EQUITY
Retained Earnings -$110.3M -$108.9M
YoY Change 42.14% 83.83%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $78.84K -$24.61M
YoY Change
Total Liabilities & Shareholders Equity $8.505M $7.041M
YoY Change -74.44% -83.94%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.455M -$2.424M
YoY Change -92.09% 79.18%
Depreciation, Depletion And Amortization $129.3K $178.2K
YoY Change -21.43% 4.2%
Cash From Operating Activities -$1.181M -$1.789M
YoY Change -28.85% -52.63%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.200M
YoY Change -76.72%
NET CHANGE
Cash From Operating Activities -1.181M -$1.789M
Cash From Investing Activities 0.000
Cash From Financing Activities 1.200M
Net Change In Cash 18.67K -$1.625M
YoY Change -100.24% -36.77%
FREE CASH FLOW
Cash From Operating Activities -$1.181M -$1.789M
Capital Expenditures $0.00
Free Cash Flow -$1.181M -$1.789M
YoY Change 165.87% -54.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001644488
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 us-gaap Investments
Investments
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2023Q2 SHRG Gain On Employee Warrants Liability
GainOnEmployeeWarrantsLiability
usd
CY2022Q2 SHRG Gain On Extinguishment Of Debt
GainOnExtinguishmentOfDebt
usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023Q2 us-gaap Increase Decrease In Other Regulatory Assets
IncreaseDecreaseInOtherRegulatoryAssets
usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023Q2 SHRG Common Stock Received On Litigation Settlement
CommonStockReceivedOnLitigationSettlement
usd
CY2023Q2 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 SHRG Sale Of Commercial Real Property In Exchange For Relief From Related Party Loans And Other Liabilities
SaleOfCommercialRealPropertyInExchangeForReliefFromRelatedPartyLoansAndOtherLiabilities
usd
CY2022Q2 SHRG Sale Of Investments In Exchange For Relief From Related Party Note And Other Liabilities
SaleOfInvestmentsInExchangeForReliefFromRelatedPartyNoteAndOtherLiabilities
usd
CY2022Q2 us-gaap Stock Issued1
StockIssued1
usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
usd
CY2023Q2 SHRG Deposits For Sales Events
DepositsForSalesEvents
usd
CY2023Q1 us-gaap Prepaid Interest
PrepaidInterest
usd
CY2023Q2 us-gaap Investments
Investments
usd
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
usd
CY2023Q2 SHRG Accrued Interest Payable
AccruedInterestPayable
usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2023Q2 us-gaap Investments
Investments
usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
usd
CY2023Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-55997
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
SHARING SERVICES GLOBAL CORPORATION
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0869786
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5200 Tennyson Parkway
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75024
CY2023Q2 dei City Area Code
CityAreaCode
(469)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
304-9400
CY2023Q2 dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
None
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
376328885 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1370146 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2994885 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
532405 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
273674 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1477563 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1636120 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1063245 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
527827 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4443359 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5432506 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
466475 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9270193 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
437419 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
448240 usd
CY2023Q1 us-gaap Investments
Investments
206231 usd
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
509558 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
545372 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1184019 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1177173 usd
CY2023Q2 us-gaap Assets
Assets
7040830 usd
CY2023Q1 us-gaap Assets
Assets
17079715 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000886 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1028510 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1955644 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2781037 usd
CY2023Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
2148162 usd
CY2023Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
2357643 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1462680 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1446503 usd
CY2023Q2 SHRG Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
24659562 usd
CY2023Q1 SHRG Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
24827086 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31226934 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
39362822 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
427203 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440478 usd
CY2023Q2 us-gaap Liabilities
Liabilities
31654137 usd
CY2023Q1 us-gaap Liabilities
Liabilities
39803300 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26091136 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26091136 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
626187 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84530493 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84619762 usd
CY2023Q2 SHRG Shares To Be Issued
SharesToBeIssued
12146 usd
CY2023Q1 SHRG Shares To Be Issued
SharesToBeIssued
12146 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108880737 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106456378 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-313474 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-308305 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-24613307 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-22723585 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7040830 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17079715 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2878121 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5303618 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
845829 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1657028 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2032292 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
3646590 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1421490 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2757800 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2287072 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4550903 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3708562 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7308703 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1676270 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3662113 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
905811 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
3120054 usd
CY2022Q2 SHRG Gain On Employee Warrants Liability
GainOnEmployeeWarrantsLiability
114960 usd
CY2023Q2 SHRG Gain On Extinguishment Of Debt
GainOnExtinguishmentOfDebt
150634 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-78632 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4884173 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
97822 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
90166 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-735987 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1969246 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2412257 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1692867 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12102 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-339857 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2424359 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1353010 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
5169 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
144267 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5169 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-144267 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2429528 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1497277 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
370934280 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
278315485 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
370934280 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278315485 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2424359 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1353010 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
178232 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
171035 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-107588 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
515728 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3412427 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
150634 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
324229 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
4884173 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39933 usd
CY2023Q2 SHRG Provisions For Obsolete Inventory
ProvisionsForObsoleteInventory
15847 usd
CY2022Q2 SHRG Provisions For Obsolete Inventory
ProvisionsForObsoleteInventory
108055 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
498196 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
206163 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
57180 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
111 usd
CY2023Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-189881 usd
CY2022Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-298812 usd
CY2022Q2 us-gaap Increase Decrease In Other Regulatory Assets
IncreaseDecreaseInOtherRegulatoryAssets
19950 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1635 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
374997 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-30259 usd
CY2023Q2 SHRG Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
123 usd
CY2022Q2 SHRG Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
4162 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
403283 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1220513 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1788977 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3776508 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136807 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136807 usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5687500 usd
CY2022Q2 SHRG Common Stock Received On Litigation Settlement
CommonStockReceivedOnLitigationSettlement
1043645 usd
CY2022Q2 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
3270174 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1373681 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
164237 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-30140 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1624740 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2569774 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2994885 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17023266 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1370145 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14453492 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
481043 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
550 usd
CY2023Q2 SHRG Sale Of Commercial Real Property In Exchange For Relief From Related Party Loans And Other Liabilities
SaleOfCommercialRealPropertyInExchangeForReliefFromRelatedPartyLoansAndOtherLiabilities
7438692 usd
CY2023Q2 SHRG Sale Of Investments In Exchange For Relief From Related Party Note And Other Liabilities
SaleOfInvestmentsInExchangeForReliefFromRelatedPartyNoteAndOtherLiabilities
1500000 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
539806 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-22723585 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-22723585 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
539806 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
5169 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2424359 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-24613307 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-24613307 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22828944 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22828944 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1211547 usd
CY2022Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
26091136 shares
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
626187 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
626187 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
144267 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1353010 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21917027 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21917027 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2900000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5300000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2400000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1400000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108900000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106500000 usd
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zwx63DpL9BRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zVwwXRNgxbHg">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to the prior periods’ data to conform with the current period’s presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zhcvQ87hizla" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zXCLXzCHqM4d">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accordance with GAAP requires the use of judgment and requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent assets and liabilities, if any. Matters that require the use of estimates and assumptions include, among others: the recoverability of accounts and notes receivable, the valuation of inventory, the useful lives of fixed assets, the assessment of long-lived assets for impairment, the nature and timing of satisfaction of multiple performance obligations resulting from contracts with customers, the allocation of the transaction price to multiple performance obligations in a sales transaction, the measurement and recognition of right-of-use assets and related lease liabilities, the valuation of share-based compensation awards, the provision for income taxes, the measurement and recognition of uncertain tax positions, the valuation of long-term debt covenants, and the valuation of loss contingencies, if any. Actual results may differ from these estimates in amounts that may be material to our consolidated financial statements. We believe that the estimates and assumptions used in the preparation of our consolidated financial statements are reasonable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Credit Card Receivables
CreditCardReceivables
200000 usd
CY2023Q1 us-gaap Credit Card Receivables
CreditCardReceivables
500000 usd
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
500000 usd
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
1300000 usd
CY2023Q2 SHRG Allowance For Obsolete Inventory
AllowanceForObsoleteInventory
895603 usd
CY2023Q1 SHRG Allowance For Obsolete Inventory
AllowanceForObsoleteInventory
880926 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
1119650 usd
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 usd
CY2022Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
600000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.08 pure
CY2022Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-08-12
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
164138 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
113896 usd
CY2023Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1000000.0 usd
CY2022Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2400000 usd
CY2023Q2 SHRG Other Assets Current Gross
OtherAssetsCurrentGross
1238886 usd
CY2023Q1 SHRG Other Assets Current Gross
OtherAssetsCurrentGross
703468 usd
CY2023Q2 SHRG Allowance For Losses Current Assets
AllowanceForLossesCurrentAssets
175641 usd
CY2023Q1 SHRG Allowance For Losses Current Assets
AllowanceForLossesCurrentAssets
175641 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1063245 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
527827 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2424359 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1353010 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
370934280 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
278315485 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
370934280 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278315485 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6320000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141697975 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1875000 shares
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2373166 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2517046 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
895603 usd
CY2023Q1 us-gaap Inventory Adjustments
InventoryAdjustments
880926 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1477563 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1636120 usd
CY2023Q2 SHRG Inventory Related Deposits
InventoryRelatedDeposits
334294 usd
CY2023Q1 SHRG Inventory Related Deposits
InventoryRelatedDeposits
288649 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
274137 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
167578 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
56548 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
105652 usd
CY2023Q1 SHRG Deposits For Sales Events
DepositsForSalesEvents
120614 usd
CY2023Q2 us-gaap Prepaid Interest
PrepaidInterest
552000 usd
CY2023Q2 us-gaap Contract With Customer Right To Recover Product Current
ContractWithCustomerRightToRecoverProductCurrent
21907 usd
CY2023Q1 us-gaap Contract With Customer Right To Recover Product Current
ContractWithCustomerRightToRecoverProductCurrent
20975 usd
CY2023Q2 SHRG Allowance For Losses Current Assets
AllowanceForLossesCurrentAssets
175641 usd
CY2023Q1 SHRG Allowance For Losses Current Assets
AllowanceForLossesCurrentAssets
175641 usd
CY2022Q2 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-4865354000000 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
27000000.0 usd
CY2023Q2 SHRG Investments Gross
InvestmentsGross
1537000 usd
CY2023Q1 SHRG Investments Gross
InvestmentsGross
1743231 usd
CY2023Q2 SHRG Allowance For Impairment Losses
AllowanceForImpairmentLosses
1537000 usd
CY2023Q1 SHRG Allowance For Impairment Losses
AllowanceForImpairmentLosses
1537000 usd
CY2023Q1 us-gaap Investments
Investments
206231 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
8952555 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1024274 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1024274 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
237042 usd
CY2023Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
237042 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
220264 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
220264 usd
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
394306 usd
CY2023Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
394306 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1875886 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10828441 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1409411 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1558248 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
466475 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9270193 usd
CY2023Q2 us-gaap Loans Assumed1
LoansAssumed1
27000000.0 usd
CY2023Q2 SHRG Deferred Sales Revenues
DeferredSalesRevenues
284231 usd
CY2023Q1 SHRG Deferred Sales Revenues
DeferredSalesRevenues
246811 usd
CY2023Q2 SHRG Liability Associated With Uncertain Tax Positions
LiabilityAssociatedWithUncertainTaxPositions
925795 usd
CY2023Q1 SHRG Liability Associated With Uncertain Tax Positions
LiabilityAssociatedWithUncertainTaxPositions
925795 usd
CY2023Q1 SHRG Accrued Interest Payable
AccruedInterestPayable
536123 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
149732 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
329762 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44273 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41385 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
551613 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
701161 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1955644 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2781037 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
551612 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533583 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-1698648 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-2172914 usd
CY2023Q2 us-gaap Convertible Debt
ConvertibleDebt
24659562 usd
CY2023Q1 us-gaap Convertible Debt
ConvertibleDebt
24827086 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
24659562 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
24827086 usd
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.003 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.8 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.210 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.013 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.028 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005 pure
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.201 pure
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
2000000.0 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.20
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27000000.0 shares
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27000000.0 usd
CY2023Q2 SHRG Consulting Expenses
ConsultingExpenses
0 usd
CY2022Q2 SHRG Consulting Expenses
ConsultingExpenses
872603 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
8444663 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
109780 usd
CY2023Q2 SHRG Gain Loss On Employee Warrants Liability
GainLossOnEmployeeWarrantsLiability
0 usd
CY2022Q2 SHRG Gain Loss On Employee Warrants Liability
GainLossOnEmployeeWarrantsLiability
114960 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
437419 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
448240 usd
CY2023Q2 SHRG Operating Lease Assets
OperatingLeaseAssets
437419 usd
CY2023Q1 SHRG Operating Lease Assets
OperatingLeaseAssets
448240 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44273 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41385 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
427203 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440478 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
471476 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
481863 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
27534 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
23178 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
98672 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
101452 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
104231 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
107011 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
109790 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
169550 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
690706 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
219230 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
471476 usd
CY2023Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
24659562 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24659562 usd
CY2023Q1 us-gaap Investments
Investments
206231 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
206231 usd
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
24827086 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24827086 usd

Files In Submission

Name View Source Status
0001493152-23-027845-index-headers.html Edgar Link pending
0001493152-23-027845-index.html Edgar Link pending
0001493152-23-027845.txt Edgar Link pending
0001493152-23-027845-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
shrg-20230630.xsd Edgar Link pending
shrg-20230630_def.xml Edgar Link unprocessable
shrg-20230630_pre.xml Edgar Link unprocessable
shrg-20230630_cal.xml Edgar Link unprocessable
shrg-20230630_lab.xml Edgar Link unprocessable